DVA
59
4
CSCO
60
3
STT
60
7
AZO
48
3
ADI
47
-2
HPE
38
-15
MRK
25
2
RIG
60
5
WY
56
3
PSX
34
4
HRL
27
-3
CINF
37
6
SEE
45
-4
TAP
51
6
BIIB
37
9
STZ
50
7
PEP
47
3
NWSA
73
15
ETR
63
-3
C
50
-4
DVA
59
4
CSCO
60
3
STT
60
7
AZO
48
3
ADI
47
-2
HPE
38
-15
MRK
25
2
RIG
60
5
WY
56
3
PSX
34
4
HRL
27
-3
CINF
37
6
SEE
45
-4
TAP
51
6
BIIB
37
9
STZ
50
7
PEP
47
3
NWSA
73
15
ETR
63
-3
C
50
-4
Financhill
Back

Bio-Path Holdings Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
18

BPTH
Bio-Path Holdings

Last Price:
0.90
Seasonality Move:
-15.1%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Bio-Path Holdings Price Quote

$0.90
-0.08 (-9.67%)
(Updated: November 6, 2024 at 2:27 AM ET)

Bio-Path Holdings Key Stats

Sell
18
Bio-Path Holdings (BPTH) is a Sell
Day range:
$0.90 - $1.00
52-week range:
$0.85 - $13.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.97%
Volume:
43.7K
Avg. volume:
2.4M
1-year change:
-92.15%
Market cap:
$2.5M
Revenue:
$0
EPS:
$-16.67

How Much Does Bio-Path Holdings Make?

Data Unavailable

Is Bio-Path Holdings Growing As A Company?

Data Unavailable

Bio-Path Holdings Stock Price Performance

What Is Bio-Path Holdings 52-Week High & Low?

Bio-Path Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bio-Path Holdings?

  • How Much Debt Does Bio-Path Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bio-Path Holdings Have?
    Cash and short term investments quarterly total is $4M
  • What Is Bio-Path Holdings’s Book Value Per Share?
    Book value per share is 0.57

Is Bio-Path Holdings Cash Flow Positive?

  • What Is BPTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is Bio-Path Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.4M
  • What Is Bio-Path Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bio-Path Holdings Return On Invested Capital

Data Unavailable

Bio-Path Holdings Earnings Date & Stock Price

Bio-Path Holdings Competitors

  • Who Are Bio-Path Holdings's Competitors?
    Below is a list of companies who compete with Bio-Path Holdings or are related in some way:
    • Aadi Bioscience Inc (AADI)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Bio-Path Holdings Dividend Yield

Bio-Path Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 24.68%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.00
Upside from Last Price: 1941.86%

Major Shareholders

  • How many BPTH shares are owned by institutional investors?
    212.6K BPTH shares are owned by institutional investors
  • How many BPTH shares are owned by insiders?
    0 BPTH shares are owned by insiders